Product Information
CLARAVIS 40 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.1672 per EA under NDC 00555105756. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
40 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555105756
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISOTRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA076135On Market Since
5/9/2003
Pharmacological Classes
Price Statistics
The NADAC for CLARAVIS 40 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1672 per EA |
|---|---|
| All-time high | $7.7744 (Jun 11, 2014) |
| All-time low | $1.9456 (Nov 20, 2024) |
| 52-week high | $2.4672 |
| 52-week low | $2.0775 |
| Median price | $3.2374 |
| Average price | $4.1725 |
| Largest weekly change | +28.0% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLARAVIS 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLARAVIS 40 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.1672 per EA (NDC 00555105756), effective Jun 24, 2026.
How has the price of CLARAVIS 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLARAVIS 40 MG CAPSULE has declined 70.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARAVIS 40 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLARAVIS 40 MG CAPSULE has ranged from a low of $1.9456 (Nov 20, 2024) to a high of $7.7744 (Jun 11, 2014), with a median of $3.2374 per EA.
Are there cheaper alternatives to CLARAVIS 40 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CLARAVIS 40 MG CAPSULE, but none are currently priced below it.
Who manufactures CLARAVIS 40 MG CAPSULE?
CLARAVIS 40 MG CAPSULE (NDC 00555105756) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification